Abstract

Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution

Author(s): Fuhrman L Clifton, Godwin Donald A, Davis R Alan

Issue: Jul/Aug 2000 - Compounding for Hospice and Cancer Patients

Page(s): 320-323

Download in electronic PDF format for $75
  • Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Page 1
  • Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Page 2
  • Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Page 3
  • Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Page 4

Abstract

5-Fluorouracil (5-FU) is used in the treatment of a variety of ophthalmic conditions, including glaucoma, pterygium, retinal detachment and premalignant eye lesions. Specifically for the treatment of pterygium, intravitreal injections of 5-FU have been extemporaneously compounded by pharmacists and typically stored in syringes. No data exist concerning the chemical and physical stability of these solutions. With this in mind, the stability of 5-FU (1 mg/0.1 mL) in 0.9% sodium chloride injection prepared in the hospital pharmacy laboratory at the University of South Carolina was studied with respect to time and temperature. Admixtures of 5-FU were aseptically prepared and stored in 1-mL tuberculin syringes. The stability of these solutions was evaluated in a freezer, in a refrigerator, at room temperature and in an oven set at 40°C. Immediately after preparation, samples were collected to determine initial concentration using a stability- indicating high-performance liquid chromatography method and to assess the pH of the solution. The same tests were repeated after one, three, five and seven days of storage. Samples were also visually inspected at these times for signs of physical incompatibility. Tuberculin syringes stored at each of the temperatures showed no signs of physical incompatibility (precipitate) or loss of drug. There was also no appreciable change in pH of the solution over the study period. This study showed that aseptically prepared 5- FU ophthalmic solutions packaged in tuberculin syringes can be stored safely for up to seven days at temperatures ranging from –10 to 40°C.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2000
Pg. 320-323
May/Jun 2004
Pg. 223-227
Author(s): Kupiec Thomas C
Sep/Oct 2016
Pg. 399-404
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 314-315
Author(s): Gupta Vishnu D, Pramar Y
Mar/Apr 1999
Pg. 158-159
Author(s): Gupta Vishnu D
Sep/Oct 2010
Pg. 421
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Jan/Feb 2025
Pg. 51
Author(s):
Nov/Dec 2016
Pg. 495-500
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 164-170
May/Jun 2000
Pg. 233-235
Author(s): Gupta Vishnu D
May/Jun 1999
Pg. 239-240
Author(s): Gupta Vishnu D
May/Jun 2012
Pg. 190-195
Author(s): McElhiney Linda F
Mar/Apr 2012
Pg. 170-173
Sep/Oct 2019
Pg. 418-421
Jul/Aug 2021
Pg. 324
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 320-322
May/Jun 2015
Pg. 242
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486
Author(s): Allen Loyd V Jr
Mar/Apr 2025
Pg. 132-140